Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subodh Verma

Showing results (311-320 of 785) with videos related to

Pageof 79
Sort By:
Circulation|October 29, 2003
Biomarkers of vascular disease linking inflammation to endothelial activation: Part IIPaul E Szmitko, Chao-Hung Wang, Richard D Weisel, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 18, 2005
Can statin therapy alter the natural history of bicuspid aortic valves?Subodh Verma, Paul E Szmitko, Paul W M Fedak, et al.
Vascular Medicine (London, England)|October 23, 2008
Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndromeLawrence M Title, Evan Lonn, Francois Charbonneau, et al.
European Heart Journal|November 15, 2023
The cardiovascular effects of novel weight loss therapiesMuhammad Shariq Usman, Melanie Davies, Michael E Hall, et al.
Journal of the American College of Cardiology|May 26, 2018
Antithrombotic Therapy for Peripheral Artery Disease: Recent AdvancesMohamad A Hussain, Mohammed Al-Omran, Mark A Creager, et al.
The American Journal of Cardiology|May 26, 2009
Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factorsAndrew C Philpott, Eva Lonn, Lawrence M Title, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 14, 2024
GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetesBrady Park, Aishwarya Krishnaraj, Hwee Teoh, et al.
Journal of Vascular Surgery|December 24, 2017
Loss of vascular smooth muscle cell autophagy exacerbates angiotensin II-associated aortic remodelingAzza Ramadan, Krishna K Singh, Adrian Quan, et al.
Diabetologia|May 20, 2018
Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trialSubodh Verma, C David Mazer, David Fitchett, et al.
Stroke|March 9, 2022
Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for NeurologistsRonald M Goldenberg, Alice Y Y Cheng, Tess Fitzpatrick, et al.
Pageof 79

Showing results (311-320 of 785) with videos related to

Sort By:
Pageof 79
Circulation|October 29, 2003
Biomarkers of vascular disease linking inflammation to endothelial activation: Part IIPaul E Szmitko, Chao-Hung Wang, Richard D Weisel, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 18, 2005
Can statin therapy alter the natural history of bicuspid aortic valves?Subodh Verma, Paul E Szmitko, Paul W M Fedak, et al.
Vascular Medicine (London, England)|October 23, 2008
Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndromeLawrence M Title, Evan Lonn, Francois Charbonneau, et al.
European Heart Journal|November 15, 2023
The cardiovascular effects of novel weight loss therapiesMuhammad Shariq Usman, Melanie Davies, Michael E Hall, et al.
Journal of the American College of Cardiology|May 26, 2018
Antithrombotic Therapy for Peripheral Artery Disease: Recent AdvancesMohamad A Hussain, Mohammed Al-Omran, Mark A Creager, et al.
The American Journal of Cardiology|May 26, 2009
Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factorsAndrew C Philpott, Eva Lonn, Lawrence M Title, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 14, 2024
GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetesBrady Park, Aishwarya Krishnaraj, Hwee Teoh, et al.
Journal of Vascular Surgery|December 24, 2017
Loss of vascular smooth muscle cell autophagy exacerbates angiotensin II-associated aortic remodelingAzza Ramadan, Krishna K Singh, Adrian Quan, et al.
Diabetologia|May 20, 2018
Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trialSubodh Verma, C David Mazer, David Fitchett, et al.
Stroke|March 9, 2022
Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for NeurologistsRonald M Goldenberg, Alice Y Y Cheng, Tess Fitzpatrick, et al.
Pageof 79